[Seminar] Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry
Discussion contents of the "Study Group on the Structure of Industry for Achieving Stable Supply of Generic Pharmaceuticals, etc."
Our company will hold a seminar titled "Ministry of Health, Labour and Welfare: Future Prospects for the Generic Pharmaceutical Industry." Generic pharmaceuticals account for over 50% of the total quantity of prescription drugs and contribute to the improvement of healthcare financing, playing an essential role as social infrastructure. On the other hand, in response to the supply shortage of generic pharmaceuticals stemming from regulatory actions against certain generic pharmaceutical companies, a study group on "the structure of the industry for achieving stable supply of generic pharmaceuticals" was established in July 2023 to engage in broad discussions about the ideal state of the generic pharmaceutical industry and the industrial policies needed to realize it. This seminar will provide detailed explanations not only of the discussions from the study group but also of the future prospects for the generic pharmaceutical industry. 【Seminar Details】 ■ Date and Time: June 13 (Thursday) 13:30 - 15:30 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Speaker: Ministry of Health, Labour and Welfare Member of the "Study Group on the Structure of the Industry for Achieving Stable Supply of Generic Pharmaceuticals" Director of the Healthcare Division, Corporate Finance Department 6, Development Bank of Japan Mr. Masafumi Nozawa *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Lecture Topics】 ■Current Status of the Generic Pharmaceutical Industry ■Various Committees Addressing Supply Issues ■Challenges and Issues for Stable Supply ■Ideal Structure of the Industry and Future Outlook ■Related Q&A ■Business Card and Information Exchange Meeting *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.
![[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country](https://image.mono.ipros.com/public/product/image/3d2/2001181608/IPROS32315136463393769928.png?w=280&h=280)
![[Seminar] Current Situation and Challenges of Supply Shortages of Medical Pharmaceuticals](https://image.mono.ipros.com/public/product/image/9e3/2001523583/IPROS7667559201004464429.png?w=280&h=280)
![[Seminar] Current Status of Stable Supply of Pharmaceuticals and Government Initiatives](https://image.mono.ipros.com/public/product/image/2079072/IPROS8378301222553094990.png?w=280&h=280)
![[Seminar] Latest Trends in Policies for Stable Supply of Generic Drugs and Corporate Collaboration](https://image.mono.ipros.com/public/product/image/2079072/IPROS10253278751703873794.png?w=280&h=280)
![[Research Material] The Global Market for Amantadine Hydrochloride](https://image.mono.ipros.com/public/product/image/a46/2001476824/IPROS79446037281167030129.jpeg?w=280&h=280)
![[Research Material] Global Market for Lysophosphatidic Acid Receptor 1](https://image.mono.ipros.com/public/product/image/abb/2000843178/IPROS50159050395682949296.jpeg?w=280&h=280)
